HomeTech & BusinessTop 10 Global Cities by R&D Pipeline Count of Biotech Startups
Top 10Updated 2026年3月15日

Top 10 Global Cities by R&D Pipeline Count of Biotech Startups

This ranking evaluates global biotech clusters based on the number of active R&D pipelines from startups (founded within 10 years). R&D pipelines serve as a core metric for regional innovation capacity, translational medicine efficacy, and venture capital density in the global biopharmaceutical industry.

Current #1
Boston

Interesting Facts & Summary

Industrial Insights

  • Dominance of the Duo: Boston and the San Francisco Bay Area maintain a lead, hosting nearly 40% of global startup pipelines.
  • The China Surge: Shanghai and Beijing show robust growth, driven by deep government support and the return of high-level scientific talent.
  • Emerging Hubs: Zurich and Basel leverage their deep-rooted pharmaceutical industrial heritage to excel in precision medicine.

Key Fact: With the rise of AI-driven drug discovery, the proportion of ADC and gene editing projects in R&D pipelines has doubled over the past two years.

RankCityPipeline CountCore Focus Areas
Boston
845Immuno-oncology, Gene Therapy
San Francisco Bay Area
792AI Drug Discovery, Digital Health
San Diego
460CNS, Metabolic Diseases
4
Shanghai
415ADCs, Biosimilars
5
London
380Synthetic Biology, Immunology
6
Cambridge (UK)
355Genomics, Proteomics
7
Beijing
330Small Molecules, Biologics
8
Basel
290Precision Medicine, Rare Diseases
9
Zurich
265Cell Therapy, Bioengineering
10
Singapore
240Infectious Diseases, Medical Devices

List Stats

Views1
Items10
CategoryTech & Business

Comments

No comments yet. Be the first to comment!